Anlon Healthcare Limited (NSE:AHCL)
India · Delayed Price · Currency is INR 14.28
-0.09 (-0.63%)
At close: Aug 21, 2026
Anlon Healthcare Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 285.14 | 205.18 | 96.57 | 58.2 | -1.08 |
Depreciation & Amortization | 15.24 | 17.74 | 18.88 | 18.66 | 18.42 |
Other Operating Activities | 129.26 | 93.07 | 40.29 | 49.62 | 40.89 |
Change in Accounts Receivable | -286.79 | -362.68 | 50.75 | -235.03 | -143.66 |
Change in Inventory | -629 | -85.5 | -147.47 | -2.77 | -50.41 |
Change in Accounts Payable | 225.49 | -3.49 | -53.34 | 100.93 | 43.18 |
Change in Other Net Operating Assets | -533.74 | -89.84 | -37.93 | -18.12 | 75.13 |
Operating Cash Flow | -794.4 | -225.52 | -32.26 | -28.5 | -17.54 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -364.19 | -5.29 | -35.32 | -3.72 | -4.78 |
Sale of Property, Plant & Equipment | - | 32.33 | 0.87 | - | - |
Cash Acquisitions | -0.48 | - | - | - | - |
Investment in Securities | -0.8 | - | - | - | - |
Other Investing Activities | 2.1 | 0.81 | 0.76 | 0.37 | 0.92 |
Investing Cash Flow | -363.37 | 27.85 | -33.69 | -3.35 | -3.86 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | 93.62 | - | 121.08 | 1.55 | - |
Long-Term Debt Issued | - | - | - | 59.09 | 159.5 |
Total Debt Issued | 93.62 | - | 121.08 | 60.64 | 159.5 |
Short-Term Debt Repaid | - | -3.28 | - | - | -90.71 |
Long-Term Debt Repaid | -322.63 | -158.88 | -39.31 | - | - |
Total Debt Repaid | -322.63 | -162.16 | -39.31 | - | -90.71 |
Net Debt Issued (Repaid) | -229.02 | -162.16 | 81.77 | 60.64 | 68.79 |
Issuance of Common Stock | 1,213 | 388.72 | 40 | - | - |
Other Financing Activities | 202.51 | -37.15 | -39.31 | -37.98 | -40.72 |
Financing Cash Flow | 1,187 | 189.42 | 82.46 | 22.66 | 28.07 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | -0 | 0 | - | - |
Net Cash Flow | 29.16 | -8.25 | 16.51 | -9.19 | 6.67 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -1,159 | -230.81 | -67.58 | -32.22 | -22.32 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -67.37% | -19.18% | -10.14% | -2.85% | -3.89% |
Free Cash Flow Per Share | -2.48 | -0.72 | -0.47 | -0.27 | -0.19 |
Levered Free Cash Flow | -1,181 | -315.27 | -201.3 | -80.42 | -91.46 |
Unlevered Free Cash Flow | -1,158 | -291.71 | -175.82 | -56.74 | -65.8 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 37.41 | 37.15 | 39.31 | 37.98 | 40.72 |
Cash Income Tax Paid | 48.56 | 10.25 | 0.13 | - | - |
Change in Working Capital | -1,224 | -541.51 | -188 | -154.98 | -75.77 |